Abstract: Sulfonatocalix [4] arenes with an appended hydroxamic acid residue can detoxify VX and related V-type neurotoxico rganophosphonates with half-lives down to 3min in aqueous buffer at 37 8 8Cand pH 7.4. The detoxification activity is attributed to the millimolar affinity of the calixarene moiety for the positively charged organophosphonates in combination with the correct arrangement of the hydroxamic acid group. The reaction involves phosphonylation of the hydroxamic acid followed by aLossen rearrangement, thus rendering the mode of action stoichiometric rather than catalytic. Nevertheless, these calixarenes are currently the most efficient low-molecular-weight compounds for detoxifying persistent V-type nerve agents under mild conditions.T hey thus represent lead structures for novel antidotes that allow treatment of poisonings by these highly toxic chemicals.
With ap ercutaneous LD 50 value of 10 mg/human, the organophosphonate (OP) O-ethyl S-[2-(diisopropylamino)ethyl] methylphosphonothioate (VX;F igure 1) is one of the most toxic and most persistent chemical warfare agents. [1] Analogues that likewise have the amino group in the side chain and the relatively stable phosphono-thioester bond are similarly harmful.
Thetoxicity of nerve agents is mainly related to their high propensity to covalently modify aserine residue in the active site of the enzyme acetylcholinesterase (AChE).
[2] In this form, AChE is unable to perform its function, namely to degrade the neurotransmitter acetylcholine,w hose accumulation leads to severe toxic effects on the central and peripheral nervous system and ultimately to death.
Ap romising concept to treat poisonings by nerve agents involves the use of proteins,s oc alled bioscavengers,t hat detoxify OPs before clinical signs occur.
[3] Bioscavengers have drawbacks,h owever, for example,l ow in vivo stability and immunogenicity,t hus rendering synthetic scavengers attractive alternatives. [4] With only af ew exceptions, [5] studies on synthetic scavengers have so far concentrated on cyclodextrin derivatives. [6] Their mode of action is expected to resemble that of proteins,w ith an initial complexation step that positions the phosphorus atom of the nerve agent close to asubstituent on the cyclodextrin ring to facilitate the reaction. Despite notable success in this context, [6] cyclodextrins that detoxify V-type nerve agents have so far remained elusive.A possible explanation could be that V-type nerve agents are poor substrates for cyclodextrins because of their protonated side chain amino groups and, hence,p olar nature at physiological pH values. [7] If this assumption is correct, hosts for ammonium ions in water should be more promising scaffolds for scavengers for V-type nerve agents.This idea is consistent with established design principles of supramolecular catalysts and reagents. [8] Ajami and Rebek proposed the use of resorcinarenederived cavitands as OP scavengers.
[5c] They described the synthesis of functionalized derivatives that could be used as ab asis for such scavengers, [9] but detoxification studies were not reported. Our approach involved the use of sulfonatocalix [4] arenes that are also strong cation binders in water. [10, 11] These calixarenes were decorated with asubstituent containing ahydroxamic acid, which is known to detoxify OPs. [12, 13] Synthesis involved the coupling of monoamine 1 [11a] to carboxylic acids with ap rotected hydroxamic acid. Deprotection followed by chromatographic purification and ion exchange afforded the products as sodium salts.Scheme 1 shows the synthesis of 2a as an example (for synthetic details, see the Supporting Information).
Of the compounds screened, 2a and 2b (Figure 2 ) exhibited highly promising properties.A nalogues 2c-e were then prepared as reference compounds.I na ddition, the sulfanilic acid derivatives 3a-c were considered to study the extent to which the calixarene moiety contributes to the activity of 2a and 2b. Ap reviously established enzymatic in vitro assay was used to obtain quantitative information about the detoxification activities of the prepared compounds (for details,see the Supporting Information). [14] Specifically,anerve agent was incubated in Tris-HCl buffer (0.1m,pH7.40) at 37 8 8Cwith an excess of at est compound. Aliquots of the solution were removed at regular time intervals to quantify their inhibitory effect on human AChE using am odified Ellman assay. [14] AChE inhibition, described quantitatively by first-order inhibition rate constants k obs ,d ecreased during incubation because of scavenger-mediated detoxification and spontaneous hydrolysis of the nerve agent. Fitting the time dependence of k obs to monoexponential decay curves yielded rate constants k that reflect how fast anerve agent loses the ability to inhibit AChE (Figure 3 ). Correcting these rate constants for the rates of spontaneous hydrolysis,d etermined by performing the assay with the same OP in the absence of any scavenger, gave rate constants k detox ,w hich were used to calculate the half-lives t 1/2 of detoxification. Tr is-HCl buffer was chosen as the medium because we typically also consider G-type nerve agents in the screening, whose spontaneous hydrolysis is too fast in phosphate buffer to allow reliable kinetic analyses. [13] [14] [15] Selected measurements were also performed in phosphate buffer to assess the influence of the buffer on the detoxification of the V-type nerve agents.I ti s worth noting that all of our detoxification studies involved the use of real nerve agents and not of less toxic simulants. Table 1s hows that the two calixarene-based hydroxamic acids 2a and 2b mediate VX detoxification with half-lives of about 5min in Tris-HCl buffer, which is approximately 3500 times faster than the spontaneous hydrolysis of VX under the same conditions.VXdetoxification induced by 2a is similarly fast in phosphate buffer. Analogues 2c and 2d,i nw hich the hydroxamic acid group is methylated at the oxygen atom or replaced by ac arboxylate group,r espectively,a re inactive. Shifting the hydroxamic acid group from the 3-position of the aromatic substituent in 2b to the 4-position in 2e also causes activity to disappear,a nd none of the reference compounds 3a-c lacking the calixarene unit detoxify VX within the timeframe of the measurement. Notably,t he activity of compounds 2a and 2b is not restricted to VX;s tructurally Table S1 for concentrations) mediated by 2a-e and 3a-c (500 mm)i nT ris-HCl buffer (0.1 m,p H7.40) at 37 8 8C. Measurements were performed at least three times and results are given as means AE the standard deviation. Forcomparison, the effects of the prepared compounds on the detoxification of soman (GD) were also assessed. Table 1 shows that the O-methylated hydroxamic acid 2c also does not mediate the detoxification of GD,which suggests that the free hydroxamic OH group is required for the reaction. The carboxylate group in 2d is presumably not sufficiently nucleophilic to have an effect. All the other compounds detoxify GD to some extent, irrespective of whether they contain ac alixarene moiety or not. Theh alf-lives of GD detoxifications by 2a and 3a or by 2b and 3b are very similar. Thus,t he detoxification of the neutral GD does not seem to benefit from the calixarene ring. By contrast, this ring is essential for the detoxification of the cationic V-type nerve agents,a snone of the sulfanilic acid derivatives exhibited notable activity.The lack of activity of the simple hydroxamic acids is consistent with the higher stability of phosphonothioates with respect to GD (the rate constants of spontaneous hydrolysis are 6.3 10 À3 min À1 for GD and 5.2 10 À5 min À1 for VX under the chosen conditions). Thea bility of 2a and 2b to overcompensate this stability difference and allow them to detoxify V-type nerve agents even faster than GD,c ould, therefore,b ea ni ndication that the predicted interactions between the calixarenes and cationic OPs indeed facilitate detoxification.
To test this assumption, binding studies were performed by using VX and the inactive calixarene derivative 2c as binding partners.Q ualitative information about complex formation was obtained by comparing the 1 HNMR spectrum of VX with that of VX in the presence of 2equiv of 2c in phosphate buffer (0.1m in D 2 O, pD 7.81). Phosphate buffer was used to avoid signals from organic buffer molecules in the 1 HNMR spectra. Figure 4s hows that the presence of 2c has apronounced effect on the resonances of the VX protons (for the effect of complexation on the receptor signals,s ee Figure S4 ). All the VX protons are shielded, with the strongest upfield shift of 1.3 ppm observed for the signals of the isopropyl-CH 3 groups.T he shifts become smaller as the distance of the respective proton from the diisopropylamino group increases,b ut effects are even evident for the resonances of the ethyl-CH 3 and P-CH 3 protons.Another notable feature is the splitting of the isopropyl-CH 3 signal into two doublets,which indicates that the stabilization of the tetrahedral ammonium group of VX upon complexation causes the isopropyl-CH 3 groups to become diastereotopic.
Thep rofound signal shifts observed in the 1 HNMR spectrum are clear indications for the binding of VX to 2c. Moreover,t he extents of the shifts suggest that complex geometries are preferred, with the cationic ammonium group located inside the calixarene cavity.A sac onsequence,t he phosphorus atom of the nerve agent should be preferentially oriented near the hydroxamic acid group of the scavenger, thus facilitating reaction. An NMR titration under the same conditions yielded abinding constant log K a of 4.11 AE 0.12 for the complex between 2c and VX, thus confirming the appreciable affinity of the sulfonatocalix [4] arene for positively charged nerve agents in water.
Efficient complexation of the nerve agents could, therefore,e xplain the detoxification activities of the calixarenebased scavengers.The different activities observed for 2a, 2b, and 2e may be related to differences in the nucleophilicities of their substituents or to structural aspects of the complexes formed. Thef ormer is less likely because benzohydroxamic acid and corresponding pyridine derivatives do not typically exhibit large differences in their pK a values or rates of reaction in the presence of OPs.
[5a,b,12a] We therefore attribute the higher activity of 2a with respect to 2b,a nd also the different rates with which the investigated nerve agents are detoxified, to structural effects of the respective complexes. Thel oss of activity when moving the hydroxamic acid from the 3-to the 4-position of the aromatic substituent may likewise be caused by the inability of the hydroxamic acid in the VX complex with 2e to efficiently reach the phosphorous atom of the nerve agent.
Information about the pathways underlying the detoxification was obtained by following the reactions between VX and calixarenes 2a and 2b by 31 PNMR spectroscopy and mass spectrometry. 31 PNMR spectroscopy showed that the spontaneous hydrolysis of VX (2.93 mm)i nT ris-HCl buffer (0.1m,p H7.40) at 37 8 8Ci sa ssociated with ap rogressive decrease in the VX signal. Concomitantly,s ignals appeared showing the formation of ethyl methylphosphonic acid (EMPA) and the toxic metabolite of VX, S-(2-(diisopropylamino)ethyl) methylphosphonothioate (EA-2192). About 25 %o ft he VX was hydrolyzed after 24 hu nder these conditions,with the EMPA/EA-2192 ratio amounting to 5.7:1.
Incubating VX (2.93 mm)i nT ris-HCl buffer (0.1m, pH 7.40) at 37 8 8Cw ith 1equiv of 2a led to an otable 78 % drop in VX concentration within the first hour of the experiment and ad rop of 94 %w hen using 2equiv of 2a, thus confirming the high detoxification ability of this scav- enger. Thed ecrease in the VX concentration after 1h was also significant in the case of 2b,b ut somewhat smaller. VX degradation was complete after 24 hi nt he presence of 2equiv of either calixarene.I nc ontrast, the residual VX reached ap lateau at 5% and 20 %w hen only 1equiv of 2a and 2b was present, respectively,which could be attributed to product inhibition, as the 2-(diisopropylamino)ethanethiol group released during VX detoxification can be expected to bind to the calixarene ring with as imilar affinity as VX. Importantly,scavenger-induced VX degradation is associated only with the formation of EMPA, thus indicating that the calixarenes mediate the selective cleavage of the PÀSbond of VX and efficiently suppress formation of the toxic metabolite EA-2192. Since analogous results were obtained for 3a and 3c,the selectivity of the reaction seems to be characteristic for hydroxamic acids,asalso observed in other studies, [4a] and not related to the calixarene moiety.
Mass spectrometry showed that VX degradation mediated by 2ais associated with the formation of amine 4 and Tr is adduct 5 shown in Scheme 2. Analogous products were observed when 2b was reacted with VX. As ac onsequence, both scavengers are consumed during the reaction, thereby rendering their mode of action stoichiometric. Thep roducts observed indicate that the reaction includes aL ossen rearrangement, as also observed for the reaction of other organophosphates with hydroxamic acids. [12] Thei socyanates resulting from this rearrangement are either hydrolyzed or react with nucleophiles,inour experiments buffer molecules, to yield the corresponding adducts.
Concluding,t his study introduces av ery promising concept for the development of synthetic scavengers for highly stable and persistent V-type nerve agents.Calixarenes 2a and 2b mediate effective detoxification of VX and other V-type nerve agents in aqueous buffer at 37 8 8Cand pH 7.4 with so far unmatched activity for synthetic compounds.T he observed high detoxification rates can be attributed to the combined presence of ar ecognition unit that binds to cationic nerve agents and ap roperly arranged nucleophilic group that mediates the selective cleavage of the PÀSb ond of the nerve agent. Relating the activities of 2a and 2b to those of bioscavengers,f or example,o nt he basis of k cat /K M values,i s difficult because the calixarenes are stoichiometric scavengers,w hile bioscavengers for VX act catalytically.D ata compiled in ar ecent review show,h owever, that half-lives of detoxification in the range of afew seconds are required for scavengers to be potentially useful in vivo.
[3b] Thus, 2a and 2b cannot replace bioscavengers yet, but their activities might allow them to be used to supplement current nerve agent therapies by shortening the period of toxicologically relevant poison concentrations.I na ddition, they should allow decontamination of skin or sensitive equipment under much milder conditions than those normally associated with VX detoxification. [1] Clearly,t hese calixarenes also represent highly promising lead structures for synthetic scavengers,w hose activities can likely be improved in the future by fine-tuning both the recognition unit and the reactive group.
